| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 301a | 0.558 | 0.808 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 342 | 0.547 | 0.769 |
|
group | 0.320 | None | 0.667 | 1 | 0 | 2010 | 2014 | |||||||||
|
microRNA 345 | 0.619 | 0.462 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
MIR31 host gene | 0.650 | 0.462 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 429 | 0.544 | 0.731 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
microRNA 489 | 0.647 | 0.423 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
KANSL1 antisense RNA 1 | 0.839 | 0.154 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
MNX1 antisense RNA 1 (head to head) | 0.615 | 0.346 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2017 | 2019 | |||||||||
|
non-coding RNA activated by DNA damage | 0.631 | 0.462 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
spectrin repeat containing nuclear envelope protein 1 | 0.511 | 0.846 | 3.2E-52 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.500 | None | 0.974 | 0 | 0 | 1996 | 2018 | ||||||||
|
dynein cytoplasmic 2 heavy chain 1 | 0.555 | 0.731 | 1.1E-44 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
CD109 molecule | 0.595 | 0.654 | 2.3E-44 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
collagen type VII alpha 1 chain | 0.545 | 0.808 | 2.4E-40 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
centromere protein F | 0.601 | 0.654 | 1.9E-36 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2000 | 2017 | ||||||||
|
ATPase copper transporting beta | 0.529 | 0.654 | 4.8E-30 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
mannosidase alpha class 2C member 1 | 0.751 | 0.269 | 2.8E-29 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.500 | None | 0.976 | 12 | 0 | 1976 | 2019 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
group | 0.370 | None | 1.000 | 3 | 0 | 2002 | 2016 | ||||||||
|
glycoprotein nmb | 0.566 | 0.692 | 2.9E-27 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2015 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2007 | 2009 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
group | 0.500 | None | 0.987 | 3 | 0 | 1995 | 2019 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.500 | None | 0.964 | 4 | 0 | 2002 | 2017 |